Clinical Trial Update: Risedronate and Parathyroid Hormone to Reverse Osteoporosis Caused by Chronic Steroid Use [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the combination of risedronate and parathyroid hormone to reverse osteoporosis caused by chronic steroid use has completed with posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Teriparatide (Teriparatide)
• risedronate (risedronate)

Snippet

Sponsor: University of California, Davis | Conditions: Osteoporosis | Phase 4 | Status: COMPLETED | Results posted: 2015-06-25